Filing Details
- Accession Number:
- 0001104659-22-086723
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-05 16:31:13
- Reporting Period:
- 2022-08-04
- Accepted Time:
- 2022-08-05 16:31:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1356576 | Supernus Pharmaceuticals Inc. | SUPN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1539494 | Tillotson Tami Martin | C/O Supernus Pharmaceuticals, Inc. 9715 Key West Avenue Rockville MD 20850 | Sr. V.p., Regulatory Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-08-04 | 5,000 | $7.90 | 92,220 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-08-04 | 5,000 | $32.98 | 87,220 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2022-08-04 | 5,000 | $0.00 | 5,000 | $7.90 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
5,000 | 2023-02-05 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to a 10b5-1 trading plan adopted May 19, 2022.
- The option vested in four equal annual installments beginning on February 5, 2014.